Strados Labs is a medical technology company reinventing how respiratory health is managed with the RESP™ Sensor Platform: the world's first FDA-cleared wearable device and SaaS solution for capturing lung health anytime, anywhere. The RESP platform is clinically validated to collect patient lung sounds continuously whether patients are at home, at the office, or in the hospital. Our proprietary machine learning algorithms allow for automated detection of events like cough, wheeze and rhonchi and objective measurement of these events overtime. The device is lightweight, hands free, HIPAA compliant with end-to-end encryption and transfers data in real-time. The RESP platform is designed for: - Clinical Research: The device is a leading technology for capturing patient respiratory symptoms, giving researchers an edge in clinical trials and assessing the efficacy of new treatments. The device collects digital biomarkers such as cough, wheeze, rhonchi and rales going beyond measuring frequency, and allows for continuous monitoring to understand patient improvement over time. - Health Systems and Clinicians: The RESP platform enables clinicians to better understand respiratory status across the patient journey and to gain a more complete picture of a patient's lung health. It allows for the potential of earlier intervention, reduced visits and readmissions. Visit our website to learn more and join us in our mission of making every breath count!